Selective anticholinergic agent that blocks muscarinic receptors, reducing gastric acid and pepsin secretion, and relieving smooth muscle spasm and associated pain; exhibits strong affinity for M receptors in gastric mucosa with minimal effect on M receptors in smooth muscle, cardiac muscle, and salivary glands, thereby causing fewer side effects on the heart, pupils, salivary glands, and gastrointestinal smooth muscle; clinically used for the treatment of acute and chronic gastric and duodenal ulcers, particularly effective in cases of excessive gastric acid secretion due to heightened vagal cholinergic tone.